Eyconis, Inc
Robert Vitti currently serves as the Chief Medical Officer at Eyconis, Inc., a position held since January 2025. Prior to this role, Robert Vitti spent 15 years at Regeneron Pharmaceuticals, ascending through the ranks from Vice President to Senior Vice President. Earlier experience includes serving as Medical Director for US Medical Affairs at Novartis from September 2005 to July 2007 and as Medical Director and Senior Manager of Business Development at Daiichi Sankyo US from January 2001 to September 2005.
This person is not in any teams
This person is not in any offices
Eyconis, Inc
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members.